Home » Topics » Gastrointestinal, BioWorld Science

Gastrointestinal, BioWorld Science
RSS

First approval for Infergen

Oct. 8, 1997

NTZ: a potential new anti-H. pylori agent

Oct. 7, 1997

Potential agent for hepatitis enters clinical trials at Bristol-Myers Squibb

Oct. 7, 1997

Nonexclusive licensing opportunity in HCV protease inhibitor research announced by Chiron

Oct. 6, 1997

Byk Gulden presents new gastric antisecretory agents

Oct. 2, 1997

Launch announced for new ulcerative colitis Rx

Oct. 1, 1997

Intron A/ribavirin combination for HCV: preliminary phase III results

Sep. 30, 1997

Pentoxifylline demonstrates gastroprotective effects in patient study

Sep. 30, 1997

L-Arginine for liver ischemia/reperfusion injury and transplantation

Sep. 25, 1997

Colonic prokinetic agent discovered by Janssen

Sep. 25, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 13, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 13, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...